International Clinical Trial: An Evaluation of the Safety and Performance of the ProstaCath System for Relieving Urinary Symptoms Secondary to Benign Prostatic Hyperplasia (BPH)

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001092381) titled 'An Evaluation of the Safety and Performance of the ProstaCath System for Relieving Urinary Symptoms Secondary to Benign Prostatic Hyperplasia (BPH)' on Sept. 4.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Non-randomised trial Masking: Open (masking not used) Assignment: Single group Type of endpoint: Safety

Primary Sponsor: ProstaCare Pty Ltd

Condition: Benign Prostate Hyperplasia (BPH) Benign Prostate Hyperplasia (BPH) Renal and Urogenital - Other renal and urogenital disorders

Intervention: The ProstaCath System is designed to treat patients with urinary symptoms associate...